SEARCH

SEARCH BY CITATION

References

  • 1
    Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. 2): II43II47.
  • 2
    Mayer EA, Gebhart GF. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 27193.
  • 3
    Cervero F, Laird JM. Visceral pain. Lancet 1999; 353: 21458.
  • 4
    Kirkup AJ, Brunsden AM, Grundy D. Receptors and Transmission in the Brain-Gut Axis: Potential for NovelTherapies. I. Receptors on visceral afferents. Am J Physiol 2001; 280: G787G794.
  • 5
    Bueno L, Fioramonti J, Garcia-Villar R. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain. Am J Physiol 2000; 278: G670G676.
  • 6
    Haley JE, Sullivan AF, Dickenson AH. Evidence for spinal N-methyl-d-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res 1990; 518: 21826.
  • 7
    Woolf CJ, Thompson SW. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 2939.
  • 8
    Coutinho SV, Meller ST, Gebhart GF. Intracolonic zymosan produces visceral hyperalgesia in the rat that is mediated by spinal NMDA and non-NMDA receptors. Brain Res 1996; 736: 715.
  • 9
    Ide Y, Maehara Y, Tsukahara S, et al. The effects of an intrathecal NMDA antagonist (AP5) on the behavioral changes induced by colorectal inflammation with turpentine in rats. Life Sci 1997; 60: 135963.
  • 10
    Olivar T, Laird JM. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes. Pain 1999; 79: 6773.
  • 11
    Ji Y, Traub RJ. Spinal NMDA receptors contribute to neuronal processing of acute noxious and nonnoxious colorectal stimulation in the rat. J Neurophysiol 2001; 86: 178391.
  • 12
    McRoberts JA, Coutinho SV, Marvizon JC, et al. Role of peripheral N-methyl-d-aspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 2001; 120: 173748.
  • 13
    Kamei J, Tanihara H, Igarashi H, et al. Effects of N-methyl-d-aspartate antagonists on the cough reflex. Eur J Pharmacol 1989; 168: 1538.
  • 14
    Fisher K, Coderre TJ, Hagen NA. Targeting the N-methyl-d-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manag 2000; 20: 35873.
  • 15
    Hewitt DJ. The use of NMDA-receptor antagonists in the treatment of chronic pain. Clin J Pain 2000; 16: S73S79.
  • 16
    Weinbroum AA, Rudick V, Paret G, et al. The role of dextromethorphan in pain control. Can J Anaesth 2000; 47: 58596.
  • 17
    Bem JL, Peck R. Dextromethorphan. An overview of safety issues. Drug Saf 1992; 7: 1909.
  • 18
    Azpiroz F, Malagelada J-R. Physiological variations in canine gastric tone measured by an electronic barostat. Am J Physiol 1985; 247: 22937.
  • 19
    Grattan TJ, Marshall AE, Higgins KS, et al. The effect of inhaled and oral dextromethorphan on citric acid induced cough in man. Br J Clin Pharmacol 1995; 39: 2613.
  • 20
    Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998; 115: 134652.
  • 21
    Zheng H, Kelly L, Patterson LM, et al. Effect of brain stem NMDA-receptor blockade by MK-801 on behavioral and fos responses to vagal satiety signals. Am J Physiol 1999; 277: R1104R1111.
  • 22
    Kawamata T, Omote K, Kawamata M, et al. Premedication with oral dextromethorphan reduces postoperative pain after tonsillectomy. Anesth Analg 1998; 86: 5947.
  • 23
    Henderson DJ, Withington BS, Wilson JA, et al. Perioperative dextromethorphan reduces postoperative pain after hysterectomy. Anesth Analg 1999; 89: 399402.
  • 24
    Nelson KA, Park KM, Robinovitz E, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48: 12128.
  • 25
    Klepstad P, Borchgrevink PC. Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia. Acta Anaesthesiol Scand 1997; 41: 4226.
  • 26
    Sivarao DV, Krowicki ZK, Abrahams TP, et al. Vagally-regulated gastric motor activity: evidence for kainate and NMDA receptor mediation. Eur J Pharmacol 1999; 368: 17382.
  • 27
    Krowicki ZK, Sivarao DV, Abrahams TP, et al. Excitation of dorsal motor vagal neurons evokes non-nicotinic receptor-mediated gastric relaxation. J Auton Nerv Syst 1999; 77: 839.
  • 28
    Jankovic SM, Milovanovic D, Matovic M, et al. The effects of excitatory amino acids on isolated gut segments of the rat. Pharmacol Res 1999; 39: 1438.
  • 29
    Nankai M, Klarica M, Fage D, et al. The pharmacology of native N-methyl-d-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 3564.
  • 30
    Zhang TY, Jahng JW, Kim DG. Dextromethorphan increases tyrosine hydroxylase mRNA in the mesencephalon of adolescent rats. Neurosci Lett 2001; 309: 858.
  • 31
    Kim HS, Park IS, Park WK. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in mice. Life Sci 1998; 63: 230511.
  • 32
    Grundy D. Neuroanatomy of visceral nociception: vagal and splanchnic afferent. Gut 2002; 51(Suppl. I): i2-i5.
  • 33
    Romita VV, Henry JL. NMDA receptor involvement in spinal inhibitory controls of nociception in the rat. Neuroreport 1996; 7: 17058.
  • 34
    Craviso GL, Musacchio JM. High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization. Mol Pharmacol 1983; 23: 61928.
  • 35
    Tortella FC, Pellicano M, Bowery NG. Dextromethorphan and neuromodulation: old drug coughs up new activities. Trends Pharmacol Sci 1989; 10: 5017.
  • 36
    Monaghan DT, Larsen H. NR1 and NR2 subunit contributions to N-methyl-d-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther 1997; 280: 61420.
  • 37
    Steinberg GK, Bell TE, Yenari MA. Dose escalation safety and tolerance study of the N-methyl-d-aspartate antagonist dextromethorphan in neurosurgery patients. J Neurosurgery 1996; 84: 8606.